Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
923.45
+35.30 (3.97%)
At close: Feb 9, 2026
Zydus Lifesciences Employees
Zydus Lifesciences had 27,917 employees as of March 31, 2025. The number of employees increased by 996 or 3.70% compared to the previous year.
Employees
27,917
Change (1Y)
996
Growth (1Y)
3.70%
Revenue / Employee
8.77M INR
Profits / Employee
1.76M INR
Market Cap
929.21B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 27,917 | 996 | 3.70% |
| Mar 31, 2024 | 26,921 | 3,895 | 16.92% |
| Mar 31, 2023 | 23,026 | -717 | -3.02% |
| Dec 31, 2022 | 23,000 | -743 | -3.13% |
| Sep 30, 2022 | 23,000 | - | - |
| Jun 30, 2022 | 23,000 | -1,412 | -5.78% |
| Mar 31, 2022 | 23,743 | -669 | -2.74% |
| Mar 31, 2021 | 24,412 | -588 | -2.35% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cipla | 30,313 |
| Aurobindo Pharma | 27,707 |
| Mankind Pharma | 26,978 |
| Alkem Laboratories | 18,785 |
| Ipca Laboratories | 16,778 |
| Glenmark Pharmaceuticals | 15,800 |
| Divi's Laboratories | 10,542 |
| Ajanta Pharma | 9,628 |
Zydus Lifesciences News
- 13 hours ago - Zydus Life shares jump over 4% as Q3 Revenue surge 30.3% YoY to Rs 6,864.5 crore, net profit rises 1.8% - Business Upturn
- 13 hours ago - Zydus Lifesciences Q3 Results: Revenue jumps 30.3% YoY to Rs 6,864.5 crore, net profit up 1.8% - Business Upturn
- 18 hours ago - Top Q3 results today, Feb 9: BSE, Zydus Lifesciences, Aurobindo Pharma, Pfizer and more to announce earnings - Business Upturn
- 5 days ago - Zydus Lifesciences receives USFDA tentative approval for Dapagliflozin Tablets - Business Upturn
- 13 days ago - Stocks to watch today, Jan 27: Infosys, Adani Enterprises, Zydus Lifesciences, ONGC, Bank of Baroda and more - Business Upturn
- 18 days ago - Zydus Lifesciences launches world’s first biosimilar of Nivolumab, ‘Tishtha’ in India - Business Upturn
- 20 days ago - Ardelyx (ARDX) Surges on Potential Acquisition by Zydus Lifesciences - GuruFocus
- 20 days ago - Ardelyx gains on report Zydus Lifesciences in talks to purchase - Seeking Alpha